scholarly journals Blood Filters in Children with COVID ‐19 and AKI : A Review

Author(s):  
Rupesh Raina ◽  
Sidharth Kumar Sethi ◽  
Ronith Chakraborty ◽  
Siddhartha Singh ◽  
Sharon Teo ◽  
...  
Keyword(s):  
1976 ◽  
Vol 5 (7) ◽  
pp. 510-511
Author(s):  
Cornelius Olcott ◽  
Robert C. Lim
Keyword(s):  

1993 ◽  
Vol 84 (1) ◽  
pp. 175-177 ◽  
Author(s):  
M. Sivakumaran ◽  
D. R. Norfolk ◽  
K. E. Major ◽  
J. A. Revill ◽  
R. M. Hutchinson ◽  
...  

1977 ◽  
Author(s):  
J.D. Barr ◽  
W.J. Chauvin ◽  
B.A. Warren ◽  
M.J. Inwood

A number of hemophiliacs, particularly on self infusion programs, avoid the use of a filtration apparatus when transfusing cryoprecipitate because it is thought Factor VIII activity is decreased, ;and it makes the procedure too cumbersome. The purpose of this study was to document that no loss of Factor VIII occurred using conventional filtration, and that blood filters are necessary. Individual and pooled units of cryoprecipitate were passed through standard blood administration sets, cryoprecipitate sets and 40 micron ultrafiltration sets. Factor VIII levels were performed on pre and post transfusion samples. The used filters were examined using conventional light, scanning (SEM), and transmission electron microscopy (TEM). No decrease in Factor VIII (p <.001) was noted when pre versus post filtration assays were compared. Examination of the filters by light microscopy demonstrated a greater than 50% obstruction of the available filter area in 39/60 units examined, and this material appeared to contain fibrin. This was substantiated by SEM and TEM examination which identified the fibrillar structure of fibrin on all filters. Furthermore, the deposits were contaminated by globular and flocculent proteinaceous material, accompanied by cellulose and plastic debris. This material passed through conventional filters, but was successfully removed by a graded 40 micron filter. This study not only demonstrates the necessity for careful filtration of cryoprecipitate prior to administration, but also identifies significant contaminating materials.


Blood ◽  
1990 ◽  
Vol 76 (10) ◽  
pp. 2159-2161
Author(s):  
BD Rawal ◽  
R Schwadron ◽  
MP Busch ◽  
R Endow ◽  
GN Vyas

The concept of reducing cell-associated blood-borne viruses (BBVs) by filtration of the vector leukocytes from blood collected for transfusion has led to the development of high efficiency filters. Improved filtration technology demands newer methodology to accurately estimate the residual cells. We have developed an experimental model based on the hemocytometer counts and the polymerase chain reaction (PCR), performed on the lymphocytes derived from the units of red cell mass inoculated with marker cells (H9) persistently carrying cell- associated human immunodeficiency virus DNA (CA-HIV). We measured the efficiency of 6 units of a prototype filter using our model and found an estimated mean of less than 4 residual cells per milliliter in the filtered blood. This represents a mean 5.84 log10 reduction of normal PBMC and CA-HIV in pre- and post-filtration aliquots and exemplifies the application of our model for evaluating a new generation of blood filters. Our model illustrates that a biological tracer (ie, DNA) is a better measure of the efficacy of a leukocyte filter than the hemocytometric enumeration of pre- and post-filtration PBMC concentrates.


Sign in / Sign up

Export Citation Format

Share Document